Preliminary results of radiotherapy for primary intraocular non-Hodgkin lymphoma.

Bibliographic Details
Title: Preliminary results of radiotherapy for primary intraocular non-Hodgkin lymphoma.
Authors: Mikami, Ryuji1 (AUTHOR) mikami-r@tokyo-med.ac.jp, Nakayama, Hidetsugu1 (AUTHOR), Goto, Hiroshi2 (AUTHOR), Kimura, Keisuke2 (AUTHOR), Usui, Yoshihiko2 (AUTHOR), Nogi, Sachika1 (AUTHOR), Tajima, Yu1 (AUTHOR), Okubo, Mitsuru1 (AUTHOR), Kanesaka, Naoto1 (AUTHOR), Sugahara, Shinji1 (AUTHOR), Tokuuye, Koichi1 (AUTHOR)
Source: Leukemia & Lymphoma. Oct2013, Vol. 54 Issue 10, p2181-2184. 4p.
Subject Terms: *HEALTH outcome assessment, *LYMPHOMA treatment, *RADIOTHERAPY, *MEDICAL radiology, *CANCER radiotherapy research
Abstract: This study aimed to retrospectively evaluate the efficacy of radiotherapy for primary intraocular non-Hodgkin lymphoma (PIOL). Between May 1998 and October 2010, 22 immunocompetent patients (four men, 18 women; median age 70 years, range 53-79 years) were diagnosed with PIOL. Magnetic resonance imaging showed no intracranial involvement in any patient. Patients received radiotherapy at a median total dose of 30 Gy (range 30-40 Gy). Three-year overall survival, progression-free survival and local control rates were 89% (95% confidence interval [CI]: 75, 103), 49% (95% CI: 24, 73) and 95% (95% CI: 86, 105) over a median of 36 months of observation, respectively. Twelve patients (55%) had intracranial relapse at a median of 28 months after initiation of radiotherapy. Visual acuity improved or was stable in 81% of treated eyes. The only grade ≥ 3 toxicity was cataract formation (five patients). Radiotherapy without chemotherapy for PIOL achieved high local control rates with acceptable toxicities. [ABSTRACT FROM AUTHOR]
Copyright of Leukemia & Lymphoma is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Academic Search Complete
Full text is not displayed to guests.
More Details
ISSN:10428194
DOI:10.3109/10428194.2013.769216
Published in:Leukemia & Lymphoma
Language:English